Home
Conditions
Neoplastic Syndromes, Hereditary

Clinical trial condition

Neoplastic Syndromes, Hereditary

Explore clinical trials studying Neoplastic Syndromes, Hereditary. Study availability and eligibility vary by location and protocol.

869 public trials 154 recruiting studies

Refine in advanced search Browse all conditions

Neoplastic Syndromes, Hereditary trial results

Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

NCT04616560

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Female Urogenital Diseases, +25 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital of Orange County Orange, California, United States

Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States

View all 28 locations

View Trial Details

Recruiting

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

NCT06880991

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas

NCT04750928

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Natural History Study of Patients With Neurofibromatosis Type 2

NCT00598351

Conditions: Central Nervous System Diseases, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +38 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

NCT06957691

Conditions: Adenocarcinoma, Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma, Androgen Deprivation Therapy, +40 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

NCT06081348

Conditions: 22Q11 Deletion, 22q11 Deletion Syndrome, ADHD, +59 more
Locations: Alberta Children's Hospital - University of Calgary Calgary, Alberta, Canada

University of Alberta-Glenrose Edmonton, Alberta, Canada

Dalhousie University - IWK Health Centre Halifax, Nova Scotia, Canada

McMaster University Hamilton, Ontario, Canada

View Trial Details

Recruiting

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

NCT06735820

Conditions: Atypical Neurofibroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, +24 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Recruiting

Evaluation of the Ileo-anal Pouch in FAP (ENDOPOL)

NCT07726771

Conditions: Adenoma, Adenomatous Polyposis Coli, Adenomatous Polyps, +18 more
Locations: St Mark's Hospital Polyposis Registry (St Mark's Centre for Familial Intestinal Cancer) London, United Kingdom

View Trial Details

Recruiting

Men at High Genetic Risk for Prostate Cancer

NCT03805919

Conditions: Colonic Diseases, Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, +22 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions: Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations: Mayo Clinic Phoenix, Arizona, United States

Honor Health Scottsdale, Arizona, United States

Arizona Cancer Center at University of Arizona Tucson, Arizona, United States

University of California, Los Angeles (UCLA) Los Angeles, California, United States

View all 33 locations

View Trial Details

Neoplastic Syndromes, Hereditary

Neoplastic Syndromes, Hereditary trial results

Related conditions